Medication info

Alenplus D Tablets

Prescription medicationExpired
Ingredient · strength
Sodium Alendronate Hydrate›Strength being verifiedCholecalciferol Concentrate Powder›Strength being verified
Manufacturer / importer
Korea Union Pharm Co., Ltd.
Appearance
White to grayish-white oblong tablets
Packaging
4 tablets/PTP x 1
Approval status
Expired

MFDS item code 201306362 · Approved 2013.03.22

This product's status changed to Expired on 2023.03.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who uses it
Adults · Children
Adult dosage
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years of treatment. The need for continued treatment should be reviewed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation after 3~5 years of treatment should be considered. Patients who discontinue treatment should be regularly reassessed for fracture risk. Other beverages or food, including mineral water and barley tea, and medicines may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce alendronate absorption in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to ensure rapid delivery to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients whose dietary calcium and vitamin D intake is inadequate should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing facilities, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentration should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this medicine provides a one-week supply of daily vitamin D at 400 IU and 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, then resume taking it on the previously scheduled day and continue regularly once weekly thereafter. Do not take 2 tablets on the same day. Administration in elderly patients (65 years and older): No dose adjustment is necessary. Administration in patients with renal impairment: No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min); however, administration of this medicine is not recommended for patients with severe renal impairment (creatinine clearance less than 35 mL/min), as there is insufficient clinical experience.
Children's dosage
Children and adolescents (under 18 years): Safety and efficacy in children and adolescents have not been established.

Ingredients

Manufacturer
Korea Union Pharm Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in postmenopausal women and men.

Dosage and Administration

Adult dosage

Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years of treatment. The need for continued treatment should be reviewed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation after 3~5 years of treatment should be considered. Patients who discontinue treatment should be regularly reassessed for fracture risk. Other beverages or food, including mineral water and barley tea, and medicines may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce alendronate absorption in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to ensure rapid delivery to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients whose dietary calcium and vitamin D intake is inadequate should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing facilities, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentration should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this medicine provides a one-week supply of daily vitamin D at 400 IU and 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, then resume taking it on the previously scheduled day and continue regularly once weekly thereafter. Do not take 2 tablets on the same day. Administration in elderly patients (65 years and older): No dose adjustment is necessary. Administration in patients with renal impairment: No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min); however, administration of this medicine is not recommended for patients with severe renal impairment (creatinine clearance less than 35 mL/min), as there is insufficient clinical experience.

Children's dosage

Children and adolescents (under 18 years): Safety and efficacy in children and adolescents have not been established.

Precautions

This medication may irritate the upper gastrointestinal tract mucosa, potentially leading to esophagitis, esophageal ulcer, or other esophageal adverse reactions. If there are any issues with the esophagus or symptoms like dysphagia, dysphagia pain, pain behind the sternum, or heartburn, discontinue the medication immediately and consult a physician. Take this medication with a sufficient amount of water, and do not lie down for at least 30 minutes after taking it. Lying down or not drinking enough water increases the risk of esophageal adverse reactions. Do not administer to patients with esophageal strictures or achalasia, those who cannot sit or stand for more than 30 minutes, those allergic to any ingredients in this medication, those with hypocalcemia, or those with certain genetic disorders. During treatment, gastrointestinal symptoms like abdominal pain, nausea, indigestion, constipation, diarrhea, acid reflux, esophagitis may occur, along with musculoskeletal pain, headaches, dizziness, or taste disturbances. This medication may hinder absorption when taken with calcium supplements or antacids, so take other medications at least 30 minutes apart. Care should be taken when taken along with aspirin or non-steroidal anti-inflammatory drugs, as it may increase the risk of gastrointestinal adverse reactions. In pregnancy, it must be administered cautiously considering the risks to the fetus, and caution is also required during breastfeeding. Not for use in children, and elderly patients or those with severely impaired kidney function should consult a doctor before use. In case of overdose, symptoms may include hypocalcemia or gastrointestinal irritation; consult a medical professional immediately, and avoid inducing vomiting. This medication should be kept out of reach of children and should not be transferred to another container for safety.

Side effects

Hemorrhage, esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, dysphagia, odynophagia, retrosternal pain, heartburn, gastric ulcer, duodenal ulcer, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, gastroesophageal reflux, esophageal ulcer, vomiting, dysphagia, abdominal distension, gastritis, musculoskeletal pain, muscle cramps, headache, dizziness, dysgeusia, rash, erythema, anastomotic ulcer, urticaria, angioedema, hypersensitivity reaction, myalgia, malaise, asthenia, fever, symptoms of hypocalcemia, peripheral edema, esophageal stricture, oropharyngeal ulcer, localized jawbone necrosis, joint swelling, low-energy fracture of the femoral neck, dizziness, vertigo, pruritus, alopecia, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, nasopharyngitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture; it should be stored in a tightly closed container. Additionally, it is best stored in a cool place away from direct sunlight at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White to grayish-white oblong tablets

Package unit

4 tablets/PTP x 1

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.